“In 2025, we reached key milestones in our fuel development program. Our team, in collaboration with
“The policy environment for nuclear energy has never been better. President Trump’s nuclear executive orders in
“We expect 2026 to be an exciting year for Lightbridge,” concluded
Financial Highlights
Working capital was approximately
Cash Flows Summary
At
- Cash used in operating activities for the year ended
December 31, 2025 was$14.3 million , an increase of$4.8 million compared to$9.5 million for the year endedDecember 31, 2024 . The increase was primarily due to elevated spending on research and development (R&D) and general and administrative expenses, partially offset by higher interest income, reflecting increased average cash balances following equity financings and higher short-term interest rates during the period. - Cash provided by financing activities for the year ended
December 31, 2025 was$176.2 million , an increase of$155.3 million compared to$20.9 million for the year endedDecember 31, 2024 . This increase was due to a$154.5 million increase in net proceeds received from the issuance of common stock under our at-the-market (“ATM”) equity offering program and a$2.3 million increase in net proceeds from the exercise of stock options, partially offset by a$1.5 million increase in the payment of withholding taxes related to the net share settlement of equity awards.- Net cash provided by our ATM facility was
$176.0 million from the sale of approximately 12.6 million common shares and$21.4 million from the sale of approximately 4.5 million common shares in 2025 and 2024, respectively.
- Net cash provided by our ATM facility was
Balance Sheet Summary
Total assets were
- Stockholders’ equity was
$203.0 million atDecember 31, 2025 , as compared to$40.5 million atDecember 31, 2024 .
Fiscal Year 2025 Operations Summary
- General and administrative expenses amounted to
$14.0 million for the fiscal year endedDecember 31, 2025 , compared to$8.5 million for the fiscal year endedDecember 31, 2024 . The$5.5 million increase was primarily due to higher stock-based compensation, professional fees, and employee compensation. - Lightbridge’s total R&D expenses amounted to
$9.2 million for the fiscal year endedDecember 31, 2025 , compared to$4.6 million for the fiscal year endedDecember 31, 2024 , an increase of$4.6 million . This increase reflected increased activities related to the development of Lightbridge Fuel, including project labor costs atIdaho National Laboratory , increases in IT expenses related to the purchase of computer hardware and software to support advanced nuclear modeling and simulation of Lightbridge Fuel, and allocated employee compensation and stock-based compensation. - Total other income was
$3.6 million for the fiscal year endedDecember 31, 2025 , compared to$1.3 million for the fiscal year endedDecember 31, 2024 . Other income consisted of interest income earned from treasury bills and our bank savings account, driven by higher average cash balances. - Net loss was
$19.6 million for the fiscal year endedDecember 31, 2025 , compared to$11.8 million for the fiscal year endedDecember 31, 2024 .
CONFERENCE CALL & AUDIO WEBCAST
To access the call by phone, please register using this link (registration link), and you will be provided with dial-in details. To avoid delays, we encourage participants to dial in to the conference call 15 minutes before the scheduled start time. The webcast can be accessed at the following link (webcast).
A webcast replay will also be available for a limited time at the following link (webcast replay).
About
To receive
Lightbridge is on X (formerly Twitter). Sign up to follow @LightbridgeCorp at http://twitter.com/lightbridgecorp.
Forward Looking Statements
With the exception of historical matters, the matters discussed herein are forward-looking statements. These statements are based on current expectations on the date of this news release and involve a number of risks and uncertainties that may cause actual results to differ significantly from such estimates. The risks include, but are not limited to: Lightbridge’s ability to commercialize its nuclear fuel technology; the degree of market adoption of Lightbridge’s product and service offerings; Lightbridge’s ability to fund general corporate overhead and outside research and development costs; market competition; our ability to attract and retain qualified employees; dependence on strategic partners; demand for fuel for nuclear reactors; Lightbridge’s ability to manage its business effectively in a rapidly evolving market; the availability of nuclear test reactors and the risks associated with unexpected changes in Lightbridge’s fuel development timeline; the increased costs associated with metallization of Lightbridge’s nuclear fuel; public perception of nuclear energy generally; changes in the political environment; risks associated with war in
A further description of risks and uncertainties can be found in Lightbridge’s Annual Report on Form 10-K for the fiscal year ended
Investor Relations Contact:
Director of Investor Relations
Tel: +1 (347) 947-2093
ir@ltbridge.com
| *** tables follow *** |
UNAUDITED CONSOLIDATED BALANCE SHEETS | ||||||||
| 2025 | 2024 | |||||||
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash and cash equivalents | $ | 201,862,421 | $ | 39,990,827 | ||||
| Prepaid expenses and other current assets | 712,983 | 324,378 | ||||||
| Total Current Assets | 202,575,404 | 40,315,205 | ||||||
| Other Assets | ||||||||
| Prepaid project costs and other long-term assets | 1,140,000 | 528,805 | ||||||
| Trademarks | 119,391 | 108,865 | ||||||
| Total Assets | $ | 203,834,795 | $ | 40,952,875 | ||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | $ | 847,451 | $ | 424,585 | ||||
| Total Current Liabilities | 847,451 | 424,585 | ||||||
| Stockholders’ Equity | ||||||||
| Preferred stock, | - | - | ||||||
| Common stock, | 33,407 | 18,784 | ||||||
| Additional paid-in capital | 386,719,120 | 204,694,348 | ||||||
| Accumulated deficit | (183,765,183 | ) | (164,184,842 | ) | ||||
| Total Stockholders’ Equity | 202,987,344 | 40,528,290 | ||||||
| Total Liabilities and Stockholders’ Equity | $ | 203,834,795 | $ | 40,952,875 | ||||
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||
| Year Ended | ||||||||
| 2025 | 2024 | |||||||
| Revenue | $ | - | $ | - | ||||
| Operating Expenses | ||||||||
| General and administrative | 14,016,573 | 8,460,519 | ||||||
| Research and development | 9,210,499 | 4,598,978 | ||||||
| Total Operating Expenses | 23,227,072 | 13,059,497 | ||||||
| Operating Loss | (23,227,072 | ) | (13,059,497 | ) | ||||
| Other Income | ||||||||
| Interest income | 3,646,731 | 1,272,431 | ||||||
| Total Other Income | 3,646,731 | 1,272,431 | ||||||
| Net Loss Before Income Taxes | (19,580,341 | ) | (11,787,066 | ) | ||||
| Income taxes | - | - | ||||||
| Net Loss | $ | (19,580,341 | ) | $ | (11,787,066 | ) | ||
| Net Loss Per Common Share | ||||||||
| Basic and diluted | $ | (0.80 | ) | $ | (0.81 | ) | ||
| Weighted Average Number of Common Shares Outstanding | 24,517,972 | 14,487,834 | ||||||
UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| Year Ended | ||||||||
| 2025 | 2024 | |||||||
| Operating Activities | ||||||||
| Net loss | $ | (19,580,341 | ) | $ | (11,787,066 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Stock-based compensation | 5,789,991 | 2,149,037 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Prepaid expenses and other current assets | (302,799 | ) | (3,121 | ) | ||||
| Prepaid project costs and other long-term assets | (611,195 | ) | (45,805 | ) | ||||
| Accounts payable and accrued liabilities | 422,866 | 193,259 | ||||||
| (14,281,478 | ) | (9,493,696 | ) | |||||
| Investing Activities | ||||||||
| Trademarks | (10,526 | ) | - | |||||
| (10,526 | ) | - | ||||||
| Financing Activities | ||||||||
| Proceeds from sale of common stock in public offerings | 181,968,400 | 22,540,789 | ||||||
| Issuance costs paid related to sale of common stock in public offerings | (6,015,819 | ) | (1,128,284 | ) | ||||
| Net proceeds from the exercise of stock options | 2,369,838 | 41,921 | ||||||
| Payments for taxes related to net share settlement of equity awards | (2,158,821 | ) | (568,348 | ) | ||||
| Net Cash Provided by Financing Activities | 176,163,598 | 20,886,078 | ||||||
| Net Increase in Cash and Cash Equivalents | 161,871,594 | 11,392,382 | ||||||
| Cash and Cash Equivalents, Beginning of Year | 39,990,827 | 28,598,445 | ||||||
| Cash and Cash Equivalents, End of Year | $ | 201,862,421 | $ | 39,990,827 | ||||
| Supplemental Disclosure of Cash Flow Information | ||||||||
| Cash paid during the year: | ||||||||
| Interest paid | $ | - | $ | - | ||||
| Income taxes paid | $ | - | $ | - | ||||
| Non-Cash Financing Activities: | ||||||||
| Payment of accrued liabilities with common stock | $ | 15,000 | $ | 15,000 | ||||
| Common stock issued for consulting services | $ | 300,000 | $ | 180,000 | ||||
Source: 